Published in PLoS Pathog on February 03, 2011
Crystal structures of beta- and gammaretrovirus fusion proteins reveal a role for electrostatic stapling in viral entry. J Virol (2013) 0.82
Structural characterization of the glycoprotein GP2 core domain from the CAS virus, a novel arenavirus-like species. J Mol Biol (2013) 0.82
Sequence variation of koala retrovirus transmembrane protein p15E among koalas from different geographic regions. Virology (2014) 0.79
Crystal structures of MBP fusion proteins. Protein Sci (2016) 0.78
A detailed molecular analysis of complete bovine leukemia virus genomes isolated from B-cell lymphosarcomas. Vet Res (2013) 0.78
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A (1982) 12.84
Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem (2001) 8.96
Viral membrane fusion. Nat Struct Mol Biol (2008) 8.54
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (1987) 7.96
A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc Natl Acad Sci U S A (1992) 5.88
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol (2000) 5.71
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol (2004) 5.29
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature (2008) 5.24
Global epidemiology of HTLV-I infection and associated diseases. Oncogene (2005) 4.77
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol (1996) 4.49
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc Natl Acad Sci U S A (1999) 3.23
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev (2008) 3.16
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci U S A (1996) 3.07
Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus. J Virol (1990) 2.36
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A (1999) 2.32
Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol (2003) 2.32
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24
HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Mol Biol Cell (2003) 2.18
Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J (2003) 1.93
The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry (2001) 1.88
LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins. J Mol Biol (1999) 1.78
The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution. J Struct Biol (1999) 1.76
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene (2005) 1.65
Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein. Protein Sci (1998) 1.45
Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation. J Virol (1992) 1.44
Leash in the groove mechanism of membrane fusion. Nat Struct Biol (2003) 1.36
HTLV-I p27rex regulates gag and env protein expression. J Acquir Immune Defic Syndr (1989) 1.34
Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry. J Biol Chem (2007) 1.34
Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibition. J Virol (2008) 1.16
Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J Virol (2000) 1.08
Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein. Virology (2005) 1.01
Crystal structure of a pivotal domain of human syncytin-2, a 40 million years old endogenous retrovirus fusogenic envelope gene captured by primates. J Mol Biol (2005) 0.97
Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides. Virology (1996) 0.96
An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein. J Virol (2003) 0.96
Turning of the receptor-binding domains opens up the murine leukaemia virus Env for membrane fusion. EMBO J (2008) 0.93
Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry. J Virol (2008) 0.82
Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope. Retrovirology (2008) 0.80
Resistance to neutralization by antibodies targeting the coiled coil of fusion-active envelope is a common feature of retroviruses. J Biol Chem (2007) 0.80
Evidence that the transmembrane domain proximal region of the human T-cell leukemia virus type 1 fusion glycoprotein gp21 has distinct roles in the prefusion and fusion-activated states. J Biol Chem (2001) 0.80
Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry. J Biol Chem (2008) 0.78
BLV and HTLV-I: their unique genomic structures and evolutionary relationship. Princess Takamatsu Symp (1984) 0.76
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86
PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol (2004) 5.10
High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3,4,5)-trisphosphate. Curr Biol (2002) 2.92
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature (2010) 2.90
The non-catalytic chitin-binding protein CBP21 from Serratia marcescens is essential for chitin degradation. J Biol Chem (2005) 2.18
Pound-wise but penny-foolish: How well do micromolecules fare in macromolecular refinement? Structure (2003) 2.14
Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science (2009) 2.13
High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site. EMBO J (2002) 1.93
Specificity and affinity of natural product cyclopentapeptide inhibitors against A. fumigatus, human, and bacterial chitinases. Chem Biol (2005) 1.80
Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J (2004) 1.77
Crystal structure and binding properties of the Serratia marcescens chitin-binding protein CBP21. J Biol Chem (2004) 1.76
Pseudokinases-remnants of evolution or key allosteric regulators? Curr Opin Struct Biol (2010) 1.76
Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins. J Biol Chem (2002) 1.71
Structure-based dissection of the natural product cyclopentapeptide chitinase inhibitor argifin. Chem Biol (2008) 1.71
Analysis of the LKB1-STRAD-MO25 complex. J Cell Sci (2004) 1.65
Structural insights into mechanism and specificity of O-GlcNAc transferase. EMBO J (2008) 1.63
Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance. Mol Cell Biol (2008) 1.63
Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis. EMBO J (2006) 1.57
ATP and MO25alpha regulate the conformational state of the STRADalpha pseudokinase and activation of the LKB1 tumour suppressor. PLoS Biol (2009) 1.47
BslA is a self-assembling bacterial hydrophobin that coats the Bacillus subtilis biofilm. Proc Natl Acad Sci U S A (2013) 1.44
Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations. Open Biol (2011) 1.42
Crystal structure of MO25 alpha in complex with the C terminus of the pseudo kinase STE20-related adaptor. Nat Struct Mol Biol (2004) 1.41
Structure and metal-dependent mechanism of peptidoglycan deacetylase, a streptococcal virulence factor. Proc Natl Acad Sci U S A (2005) 1.31
TAK1-binding protein 1 is a pseudophosphatase. Biochem J (2006) 1.30
GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels. J Am Chem Soc (2006) 1.28
Structures of Bacillus subtilis PdaA, a family 4 carbohydrate esterase, and a complex with N-acetyl-glucosamine. FEBS Lett (2004) 1.28
Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J Virol (2003) 1.26
Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes. Chem Biol (2005) 1.22
O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis. Nat Chem Biol (2012) 1.22
Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes. J Biol Chem (2003) 1.21
High-resolution structures of a chitinase complexed with natural product cyclopentapeptide inhibitors: mimicry of carbohydrate substrate. Proc Natl Acad Sci U S A (2002) 1.20
Structural insights into the recognition of substrates and activators by the OSR1 kinase. EMBO Rep (2007) 1.16
The Vibrio cholerae colonization factor GbpA possesses a modular structure that governs binding to different host surfaces. PLoS Pathog (2012) 1.14
High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family. J Biol Chem (2002) 1.12
Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis. Biochem J (2006) 1.11
GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation. Biochem J (2009) 1.10
Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b. J Biol Chem (2006) 1.09
Role of T-loop phosphorylation in PDK1 activation, stability, and substrate binding. J Biol Chem (2005) 1.09
Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket. J Biol Chem (2004) 1.07
Screening-based discovery and structural dissection of a novel family 18 chitinase inhibitor. J Biol Chem (2006) 1.05
Structure and mechanism of chitin deacetylase from the fungal pathogen Colletotrichum lindemuthianum. Biochemistry (2006) 1.05
Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1. Structure (2004) 1.04
PAS domains. Common structure and common flexibility. J Biol Chem (2003) 1.03
Structure of Saccharomyces cerevisiae chitinase 1 and screening-based discovery of potent inhibitors. Chem Biol (2007) 1.03
The N-acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase of glycosylphosphatidylinositol biosynthesis is a zinc metalloenzyme. J Biol Chem (2005) 1.03
The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design. Biochem J (2006) 1.02
Structure-based exploration of cyclic dipeptide chitinase inhibitors. J Med Chem (2004) 1.02
Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry. J Proteome Res (2013) 1.02
Human OGA binds substrates in a conserved peptide recognition groove. Biochem J (2010) 1.02
Natural product family 18 chitinase inhibitors. Nat Prod Rep (2005) 1.00
Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases. Chem Biol (2010) 1.00
Crystal structures of allosamidin derivatives in complex with human macrophage chitinase. J Biol Chem (2003) 0.99
Molecular mechanisms of O-GlcNAcylation. Curr Opin Struct Biol (2008) 0.98
Structural basis of reduction-dependent activation of human cystatin F. J Biol Chem (2006) 0.97
An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein. J Virol (2003) 0.96
Molecular mechanisms of yeast cell wall glucan remodeling. J Biol Chem (2008) 0.95
An efficient synthesis of argifin: a natural product chitinase inhibitor with chemotherapeutic potential. Bioorg Med Chem Lett (2005) 0.94
Structure of the D142N mutant of the family 18 chitinase ChiB from Serratia marcescens and its complex with allosamidin. Biochim Biophys Acta (2004) 0.93
Solid-phase synthesis of cyclic peptide chitinase inhibitors: SAR of the argifin scaffold. Org Biomol Chem (2008) 0.92
Chemical dissection of the link between streptozotocin, O-GlcNAc, and pancreatic cell death. Chem Biol (2008) 0.92
Structure of the OSR1 kinase, a hypertension drug target. Proteins (2008) 0.91
Human YKL-39 is a pseudo-chitinase with retained chitooligosaccharide-binding properties. Biochem J (2012) 0.90
Synergy of peptide and sugar in O-GlcNAcase substrate recognition. Chem Biol (2012) 0.90
Substrate and product analogues as human O-GlcNAc transferase inhibitors. Amino Acids (2010) 0.90
Interactions of a family 18 chitinase with the designed inhibitor HM508 and its degradation product, chitobiono-delta-lactone. J Biol Chem (2003) 0.89
Protein O-GlcNAcylation is required for fibroblast growth factor signaling in Drosophila. Sci Signal (2011) 0.87
Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds. FEBS Lett (2009) 0.87
Novel inositol phospholipid headgroup surrogate crystallized in the pleckstrin homology domain of protein kinase Balpha. ACS Chem Biol (2007) 0.87
The cyclic dipeptide CI-4 [cyclo-(l-Arg-d-Pro)] inhibits family 18 chitinases by structural mimicry of a reaction intermediate. Biochem J (2002) 0.86
Viral interference with host mRNA surveillance, the nonsense-mediated mRNA decay (NMD) pathway, through a new function of HTLV-1 Rex: implications for retroviral replication. Microbes Infect (2013) 0.86
Molecular mechanism of elongation factor 1A inhibition by a Legionella pneumophila glycosyltransferase. Biochem J (2010) 0.85
Streptococcus mutans SMU.623c codes for a functional, metal-dependent polysaccharide deacetylase that modulates interactions with salivary agglutinin. J Bacteriol (2008) 0.85
IQGAP proteins reveal an atypical phosphoinositide (aPI) binding domain with a pseudo C2 domain fold. J Biol Chem (2012) 0.85
Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain. Open Biol (2013) 0.84
Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors. Biochem J (2014) 0.84
Phenotypic analysis of human immunodeficiency virus type 1 Rev trimerization-interface mutants in human cells. J Gen Virol (2005) 0.82
Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry. J Virol (2008) 0.82
Structural and kinetic differences between human and Aspergillus fumigatus D-glucosamine-6-phosphate N-acetyltransferase. Biochem J (2008) 0.81
Structural and functional characterization of a putative polysaccharide deacetylase of the human parasite Encephalitozoon cuniculi. Protein Sci (2009) 0.81
Acetazolamide-based fungal chitinase inhibitors. Bioorg Med Chem (2010) 0.81
Natural product-guided discovery of a fungal chitinase inhibitor. Chem Biol (2010) 0.81
Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope. Retrovirology (2008) 0.80
Elevated O-GlcNAc levels activate epigenetically repressed genes and delay mouse ESC differentiation without affecting naïve to primed cell transition. Stem Cells (2014) 0.80
Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread. Antimicrob Agents Chemother (2008) 0.80
Resistance to neutralization by antibodies targeting the coiled coil of fusion-active envelope is a common feature of retroviruses. J Biol Chem (2007) 0.80
Glucose-6-phosphate as a probe for the glucosamine-6-phosphate N-acetyltransferase Michaelis complex. FEBS Lett (2007) 0.80
Genetic and structural validation of Aspergillus fumigatus UDP-N-acetylglucosamine pyrophosphorylase as an antifungal target. Mol Microbiol (2013) 0.79
An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function. J Gen Virol (2007) 0.79
Yeast Mnn9 is both a priming glycosyltransferase and an allosteric activator of mannan biosynthesis. Open Biol (2013) 0.78